Dexcom Inc [DXCM] stock prices are down -0.94% to $89.68 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The DXCM shares have gain 3.82% over the last week, with a monthly amount glided 6.28%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dexcom Inc [NASDAQ: DXCM] stock has seen the most recent analyst activity on February 03, 2025, when Redburn Atlantic upgraded its rating to a Buy and also boosted its price target to $115 from $85. Previously, Robert W. Baird upgraded its rating to Outperform on January 16, 2025, and elevated its price target to $104. On July 26, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $80 on the stock. JP Morgan downgraded its rating to a Neutral and decreased its price target to $75 on July 26, 2024. Redburn Atlantic initiated its recommendation with a Neutral and recommended $130 as its price target on May 30, 2024. RBC Capital Mkts started tracking with a Outperform rating for this stock on March 12, 2024, and assigned it a price target of $165.
The stock price of Dexcom Inc [DXCM] has been fluctuating between $62.34 and $142.00 over the past year. Currently, Wall Street analysts expect the stock to reach $110 within the next 12 months. Dexcom Inc [NASDAQ: DXCM] shares were valued at $89.68 at the most recent close of the market. An investor can expect a potential return of 22.66% based on the average DXCM price forecast.
Analyzing the DXCM fundamentals
The Dexcom Inc [NASDAQ:DXCM] reported sales of 4.03B for trailing twelve months, representing a surge of 7.64%. Gross Profit Margin for this corporation currently stands at 0.6% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.18%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.09, Equity is 0.26 and Total Capital is 0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.2.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 88.62 points at the first support level, and at 87.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 91.24, and for the 2nd resistance point, it is at 92.80.
Ratios To Look Out For
It’s worth pointing out that Dexcom Inc [NASDAQ:DXCM]’s Current Ratio is 1.47. Further, the Quick Ratio stands at 1.28, while the Cash Ratio is 0.21. Considering the valuation of this stock, the price to sales ratio is 8.69, the price to book ratio is 16.66 and price to earnings (TTM) ratio is 62.95.
Transactions by insiders
Recent insider trading involved Sylvain Jereme M, EVP, Chief Financal Officer, that happened on Jan 29 ’25 when 2090.0 shares were sold. EVP, Strategy & Corporate Dev, Dolan Matthew Vincent completed a deal on Jan 29 ’25 to sell 1183.0 shares. Meanwhile, EVP, Chief HR Officer Stern Sadie sold 2093.0 shares on Jan 29 ’25.
